ReviewThe Canadian journal of cardiology2007
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.
Review in The Canadian journal of cardiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 153 citations in OpenAlex.
- The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.The Canadian journal of cardiology · 2010Guideline
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.The Canadian journal of cardiology · 2009Guideline
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.The Canadian journal of cardiology · 2008Guideline
- Trial
- Self-Management of Medications During Sick Days for Chronic Conditions: A Scoping Review.Medicina (Kaunas, Lithuania) · 2025Article
- Managing 'sick days' in patients with chronic conditions: An exploration of patient and healthcare provider experiences.Health expectations : an international journal of public participation in health care and health policy · 2023Article
- The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Inpatients With Heart Failure.CJC open · 2022Article
- Approach to advanced heart failure at the end of life.Canadian family physician Medecin de famille canadien · 2017Review
- A Scoping Review of Frailty and Acute Care in Middle-Aged and Older Individuals with Recommendations for Future Research.Canadian geriatrics journal : CGJ · 2017Article
- Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides - The Case for Soluble ST2.European cardiology · 2015Review
- Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure.Proteomics · 2013Article
- Novel pharmacologic therapies in development for acute decompensated heart failure.Current cardiology reports · 2013Review
- Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches.European heart journal. Acute cardiovascular care · 2012Article
- Pregnancy in a patient with cancer and heart failure: challenges and complexities.Journal of the advanced practitioner in oncology · 2012Article
- Anemia in heart failure patients.ISRN hematology · 2012Article
- Prospective care of heart failure in Japan: lessons from CHART studies.The EPMA journal · 2011Article
- Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.Canadian family physician Medecin de famille canadien · 2011Article
- Prediction of emergent heart failure death by semi-quantitative triage risk stratification.PloS one · 2011Article
- Cardiorenal syndrome: an unsolved clinical problem.International journal of nephrology · 2011Article
- Targeting success in heart failure: evidence-based management.Canadian family physician Medecin de famille canadien · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 9 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure is common, yet it is difficult to treat. It presents in many different guises and circumstances in which therapy needs to be individualized. The Canadian Cardiovascular Society published a comprehensive set of recommendations in January 2006 on the diagnosis and management of heart failure, and the present update builds on those core recommendations. Based on feedback obtained through a national program of heart failure workshops during 2006, several topics were identified as priorities because of the challenges they pose to health care professionals. New evidence-based recommendations were developed using the structured approach for the review and assessment of evidence adopted and previously described by the Society. Specific recommendations and practical tips were written for the prevention of heart failure, the management of heart failure during intercurrent illness, the treatment of acute heart failure, and the current and future roles of biomarkers in heart failure care. Specific clinical questions that are addressed include: which patients should be identified as being at high risk of developing heart failure and which interventions should be used? What complications can occur in heart failure patients during an intercurrent illness, how should these patients be monitored and which medications may require a dose adjustment or discontinuation? What are the best therapeutic, both drug and nondrug, strategies for patients with acute heart failure? How can new biomarkers help in the treatment of heart failure, and when and how should BNP be measured in heart failure patients? The goals of the present update are to translate best evidence into practice, to apply clinical wisdom where evidence for specific strategies is weaker, and to aid physicians and other health care providers to optimally treat heart failure patients to result in a measurable impact on patient health and clinical outcomes in Canada.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.